Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Platycodin D
Cat. No.:
0225LY-1008
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Platycodin D serves as an expectorant for airway diseases by increasing mucin release and suppressing prostaglandin E2 production; it may also influence TNF-α synthesis or mRNA degradation.
Synonym:
58479-68-8; PlatycodinD; Platycodin-D; Olean-12-en-28-oic acid, 3-(beta-D-glucopyranosyloxy)-2,16,23,24-tetrahydroxy-, O-D-apio-beta-D-furanosyl-(1-3)-O-beta-D-xylopyranosyl-(1-4)-O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-L-arabinopyranosyl ester, (2beta,3beta,16alpha)-; MFCD09952590
CAS No.:
58479-68-8
Compound CID:
162859
Formula:
C57H92O28
Formula Weight:
1225.32
Specification
Relative Density:
1.56 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Platycodin D can be used in immunology research to study its potential as a vaccine adjuvant and its anti-inflammatory biological actions.
Library Information
Target:
Prostaglandin receptor; AMPK
Receptor:
AMPK; PGE2
Pathways:
Immunology/Inflammation; GPCR/G protein signaling; PI3K/Akt/mTOR signaling; Chromatin/Epigenetic
Plate Number:
AOCL-13
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
45 mg/mL; 36.73 mM
